1. Biochemistry and Chemical Biology
  2. Plant Biology
Download icon

Two bifunctional inositol pyrophosphate kinases/phosphatases control plant phosphate homeostasis

  1. Jinsheng Zhu
  2. Kelvin Lau
  3. Robert Puschmann
  4. Robert K Harmel
  5. Youjun Zhang
  6. Verena Pries
  7. Philipp Gaugler
  8. Larissa Broger
  9. Amit K Dutta
  10. Henning J Jessen
  11. Gabriel Schaaf
  12. Alisdair R Fernie
  13. Ludwig A Hothorn
  14. Dorothea Fiedler
  15. Michael Hothorn  Is a corresponding author
  1. University of Geneva, Switzerland
  2. Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Germany
  3. Max-Planck Institute of Molecular Plant Physiology, Germany
  4. University of Bonn, Germany
  5. Albert-Ludwigs-Universität Freiburg, Germany
  6. Max-Planck Institute for Molecular Plant Physiology, Germany
  7. Leibniz University, Germany
Research Article
  • Cited 24
  • Views 3,097
  • Annotations
Cite this article as: eLife 2019;8:e43582 doi: 10.7554/eLife.43582

Abstract

Many eukaryotic proteins regulating phosphate (Pi) homeostasis contain SPX domains that are receptors for inositol pyrophosphates (PP-InsP), suggesting that PP-InsPs may regulate Pi homeostasis. Here we report that deletion of two diphosphoinositol pentakisphosphate kinases VIH1/2 impairs plant growth and leads to constitutive Pi starvation responses. Deletion of phosphate starvation response transcription factors partially rescues vih1 vih2 mutant phenotypes, placing diphosphoinositol pentakisphosphate kinases in plant Pi signal transduction cascades. VIH1/2 are bifunctional enzymes able to generate and break-down PP-InsPs. Mutations in the kinase active site lead to increased Pi levels and constitutive Pi starvation responses. ATP levels change significantly in different Pi growth conditions. ATP-Mg2+ concentrations shift the relative kinase and phosphatase activities of diphosphoinositol pentakisphosphate kinases in vitro. Pi inhibits the phosphatase activity of the enzyme. Thus, VIH1 and VIH2 relay changes in cellular ATP and Pi concentrations to changes in PP-InsP levels, allowing plants to maintain sufficient Pi levels.

Article and author information

Author details

  1. Jinsheng Zhu

    Structural Plant Biology Laboratory, Department of Botany and Plant Biology, University of Geneva, Geneve, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8131-1876
  2. Kelvin Lau

    Structural Plant Biology Laboratory, Department of Botany and Plant Biology, University of Geneva, Geneve, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  3. Robert Puschmann

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6443-2326
  4. Robert K Harmel

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Youjun Zhang

    Max-Planck Institute of Molecular Plant Physiology, Potsdam-Golm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Verena Pries

    Department of Plant Nutrition, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Philipp Gaugler

    Department of Plant Nutrition, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Larissa Broger

    Structural Plant Biology Laboratory, Department of Botany and Plant Biology, University of Geneva, Geneve, Switzerland
    Competing interests
    The authors declare that no competing interests exist.
  9. Amit K Dutta

    Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Henning J Jessen

    Institute of Organic Chemistry, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Gabriel Schaaf

    Institute of Crop Science and Resource Conservation, Department of Plant Nutrition, University of Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Alisdair R Fernie

    Max-Planck Institute for Molecular Plant Physiology, Potsdam-Golm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Ludwig A Hothorn

    Institute of Biostatistics, Leibniz University, Hannover, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Dorothea Fiedler

    Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Michael Hothorn

    Structural Plant Biology Laboratory, Department of Botany and Plant Biology, University of Geneva, Geneve, Switzerland
    For correspondence
    michael.hothorn@unige.ch
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3597-5698

Funding

H2020 European Research Council (310856)

  • Michael Hothorn

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII5_170925)

  • Dorothea Fiedler
  • Michael Hothorn

Howard Hughes Medical Institute (55008733)

  • Michael Hothorn

European Molecular Biology Organization (ALTF 493-2015)

  • Kelvin Lau

Leibniz-Gemeinschaft (SAW-2017-FMP-1)

  • Dorothea Fiedler

Deutsche Forschungsgemeinschaft (SCHA 1274/4-1)

  • Gabriel Schaaf

Max-Planck-Gesellschaft

  • Youjun Zhang
  • Alisdair R Fernie

Horizon 2020 Framework Programme (PlantaSYST)

  • Youjun Zhang
  • Alisdair R Fernie

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jürgen Kleine-Vehn, University of Natural Resources and Life Sciences, Austria

Publication history

  1. Received: November 12, 2018
  2. Accepted: August 21, 2019
  3. Accepted Manuscript published: August 22, 2019 (version 1)
  4. Version of Record published: September 6, 2019 (version 2)

Copyright

© 2019, Zhu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,097
    Page views
  • 577
    Downloads
  • 24
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Biochemistry and Chemical Biology
    Rajendra Uprety et al.
    Research Article Updated

    Controlling receptor functional selectivity profiles for opioid receptors is a promising approach for discovering safer analgesics; however, the structural determinants conferring functional selectivity are not well understood. Here, we used crystal structures of opioid receptors, including the recently solved active state kappa opioid complex with MP1104, to rationally design novel mixed mu (MOR) and kappa (KOR) opioid receptor agonists with reduced arrestin signaling. Analysis of structure-activity relationships for new MP1104 analogs points to a region between transmembrane 5 (TM5) and extracellular loop (ECL2) as key for modulation of arrestin recruitment to both MOR and KOR. The lead compounds, MP1207 and MP1208, displayed MOR/KOR Gi-partial agonism with diminished arrestin signaling, showed efficient analgesia with attenuated liabilities, including respiratory depression and conditioned place preference and aversion in mice. The findings validate a novel structure-inspired paradigm for achieving beneficial in vivo profiles for analgesia through different mechanisms that include bias, partial agonism, and dual MOR/KOR agonism.

    1. Biochemistry and Chemical Biology
    Rachel Knoener et al.
    Tools and Resources

    HIV-1 generates unspliced (US), partially spliced (PS), and completely spliced (CS) classes of RNAs, each playing distinct roles in viral replication. Elucidating their host protein ‘interactomes’ is crucial to understanding virus-host interplay. Here, we present HyPR-MSSV for isolation of US, PS, and CS transcripts from a single population of infected CD4+ T-cells and mass spectrometric identification of their in vivo protein interactomes. Analysis revealed 212 proteins differentially associated with the unique RNA classes, including preferential association of regulators of RNA stability with US and PS transcripts and, unexpectedly, mitochondria-linked proteins with US transcripts. Remarkably, >80 of these factors screened by siRNA knockdown impacted HIV-1 gene expression. Fluorescence microscopy confirmed several to co-localize with HIV-1 US RNA and exhibit changes in abundance and/or localization over the course of infection. This study validates HyPR-MSSV for discovery of viral splice variant protein interactomes and provides an unprecedented resource of factors and pathways likely important to HIV-1 replication.